Immunohistologic detection of ACE may be a valuable diagnostic marker for differentiating renal cell carcinoma from extrarenal carcinomas.
Answers are grounded in this paper and cite their sources.
ACE immunostaining may differentiate renal cell from extrarenal carcinomas; hypothesis-generating and requires validation in larger cohorts.
Angiotensin converting enzyme (ACE) was studied in specimens of human renal cell carcinoma by indirect immunofluorescence using rabbit antibody to human kidney ACE and fluorescein-labeled goat antibody to rabbit immunoglobulin. ACE was demonstrated in the cells of all renal cell carcinomas from 10 patients and in the cultured cells set up from 4 of them, but not in any cells of 12 extrarenal carcinomas of prostate, lung, and alimentary tract. These results suggest that immunohistologic detection of ACE is of value in the histologic diagnosis of renal cell carcinoma.
No takes yet. Share an insight, caveat, or question.
Takada et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: